REVIEW ARTICLE

You have free access to this content

Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens

  1. M. Popova1,
  2. P. Molimard2,
  3. S. Courau2,
  4. J. Crociani3,
  5. C. Dufour3,
  6. F. Le Vacon1,
  7. T. Carton1,*

Article first published online: 3 AUG 2012

DOI: 10.1111/j.1365-2672.2012.05394.x

Issue

Journal of Applied Microbiology

Journal of Applied Microbiology

Volume 113, Issue 6, pages 1305–1318, December 2012

Additional Information

How to Cite

Popova, M., Molimard, P., Courau, S., Crociani, J., Dufour, C., Le Vacon, F. and Carton, T. (2012), Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens. Journal of Applied Microbiology, 113: 1305–1318. doi: 10.1111/j.1365-2672.2012.05394.x

Author Information

  1. 1

    Biofortis, Saint Herblain, France

  2. 2

    Merck Médication Familiale, Dijon Cedex, France

  3. 3

    Silliker, Cergy-Pontoise, France

* Correspondence
Thomas Carton, Biofortis, 3, route de la Chatterie, 44800 Saint Herblain, France. E-mail: thomas.carton@mxns.com

Publication History

  1. Issue published online: 16 NOV 2012
  2. Article first published online: 3 AUG 2012
  3. Accepted manuscript online: 13 JUL 2012 03:20AM EST
  4. Manuscript Accepted: 5 JUL 2012
  5. Manuscript Revised: 22 JUN 2012
  6. Manuscript Received: 2 MAY 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (144K)

References

  • Allen, S.J., Martinez, E.G., Gregorio, G.V. and Dans, L.F. (2010) Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 11, CD003048.
  • Alvarez-Olmos, M.I. and Oberhelman, R.A. (2001) Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 32, 1567–1576.
  • Aslim, B., Onal, D. and Beyatli, Y. (2007) Factors influencing autoaggregation and aggregation of Lactobacillus delbrueckii subsp. bulgaricus isolated from handmade yogurt. J Food Prot 70, 223–227.
  • Banerjee, P., Merkel, G.J. and Bhunia, A.K. (2009) Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog 1, 8.
  • Berggren, A., Lazou Ahren, I., Larsson, N. and Onning, G. (2011) Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr 50, 203–210.
  • Bernet, M.F., Brassart, D., Neeser, J.R. and Servin, A.L. (1994) Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35, 483–489.
  • Bernstein, J.M., Haase, E., Scannapieco, F., Dryja, D., Wolf, J., Briles, D., King, J. and Wilding, G.E. (2006) Bacterial interference of penicillin-sensitive and -resistant Streptococcus pneumoniae by Streptococcus oralis in an adenoid organ culture: implications for the treatment of recurrent upper respiratory tract infections in children and adults. Ann Otol Rhinol Laryngol 115, 350–356.
  • Boris, S., Suarez, J.E., Vazquez, F. and Barbes, C. (1998) Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 66, 1985–1989.
  • Bourke, S.J. (2007) Lecture Notes: Respiratory Medicine. Oxford, UK: Blackwell Publishing.
  • Burton, J.P., Wescombe, P.A., Moore, C.J., Chilcott, C.N. and Tagg, J.R. (2006) Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol 72, 3050–3053.
  • Burton, J.P., Cowley, S., Simon, R.R., McKinney, J., Wescombe, P.A. and Tagg, J.R. (2011) Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol 49, 2356–2364.
  • Candela, M., Perna, F., Carnevali, P., Vitali, B., Ciati, R., Gionchetti, P., Rizzello, F., Campieri, M. et al. (2008) Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int J Food Microbiol 125, 286–292.
  • Chauviere, G., Coconnier, M.H., Kerneis, S., Fourniat, J. and Servin, A.L. (1992) Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells. J Gen Microbiol 138 (Pt 8), 1689–1696.
  • Coconnier, M.H., Klaenhammer, T.R., Kerneis, S., Bernet, M.F. and Servin, A.L. (1992) Protein-mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture. Appl Environ Microbiol 58, 2034–2039.
  • Coconnier, M.H., Bernet, M.F., Chauviere, G. and Servin, A.L. (1993) Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cells. J Diarrhoeal Dis Res 11, 235–242.
  • Collado, M.C., Meriluoto, J. and Salminen, S. (2007) Measurement of aggregation properties between probiotics and pathogens: in vitro evaluation of different methods. J Microbiol Methods 71, 71–74.
  • Comelli, E.M., Guggenheim, B., Stingele, F. and Neeser, J.R. (2002) Selection of dairy bacterial strains as probiotics for oral health. Eur J Oral Sci 110, 218–224.
    Direct Link:
  • Coudeyras, S., Jugie, G., Vermerie, M. and Forestier, C. (2008) Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens. Infect Dis Obstet Gynecol 2008, 549640.
  • EFSA (2007) Opinion of the Scientific Committee on a request from EFSA on the introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA. The EFSA J 587, 1–16.
  • Falck, G., Grahn-Hakansson, E., Holm, S.E., Roos, K. and Lagergren, L. (1999) Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol 119, 944–948.
  • FAO/WHO (2001) Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Cordoba: FAO/WHO.
  • Fernandez, M.F., Boris, S. and Barbes, C. (2003) Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J Appl Microbiol 94, 449–455.
    Direct Link:
  • Forestier, C., De Champs, C., Vatoux, C. and Joly, B. (2001) Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res Microbiol 152, 167–173.
  • Girardin, M. and Seidman, E.G. (2011) Indications for the use of probiotics in gastrointestinal diseases. Dig Dis 29, 574–587.
  • Gluck, U. and Gebbers, J.O. (2003) Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 77, 517–520.
  • Gopal, P.K., Prasad, J., Smart, J. and Gill, H.S. (2001) In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int J Food Microbiol 67, 207–216.
  • Greene, J.D. and Klaenhammer, T.R. (1994) Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl Environ Microbiol 60, 4487–4494.
  • Guglielmetti, S., Taverniti, V., Minuzzo, M., Arioli, S., Stuknyte, M., Karp, M. and Mora, D. (2010a) Oral bacteria as potential probiotics for the pharyngeal mucosa. Appl Environ Microbiol 76, 3948–3958.
  • Guglielmetti, S., Taverniti, V., Minuzzo, M., Arioli, S., Zanoni, I., Stuknyte, M., Granucci, F., Karp, M. et al. (2010b) A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response. Infect Immun 78, 4734–4743.
  • Guillemard, E., Tondu, F., Lacoin, F. and Schrezenmeir, J. (2010) Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr 103, 58–68.
  • Gupta, G. (2011) Probiotics and periodontal health. J Med Life 4, 387–394.
  • Halldorsdottir, H.D., Haraldsdottir, V., Bodvarsson, A., Thorgeirsson, G. and Kristjansson, M. (2002) Endocarditis caused by Lactococcus cremoris. Scand J Infect Dis 34, 205–206.
  • Hatakka, K., Savilahti, E., Ponka, A., Meurman, J.H., Poussa, T., Nase, L., Saxelin, M. and Korpela, R. (2001) Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322, 1327.
  • Hatakka, K., Blomgren, K., Pohjavuori, S., Kaijalainen, T., Poussa, T., Leinonen, M., Korpela, R. and Pitkaranta, A. (2007) Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study. Clin Nutr 26, 314–321.
  • Haukioja, A., Yli-Knuuttila, H., Loimaranta, V., Kari, K., Ouwehand, A.C., Meurman, J.H. and Tenovuo, J. (2006) Oral adhesion and survival of probiotic and other lactobacilli and bifidobacteria in vitro. Oral Microbiol Immunol 21, 326–332.
    Direct Link:
  • He, F., Ouwehand, A.C., Isolauri, E., Hosoda, M., Benno, Y. and Salminen, S. (2001) Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. Curr Microbiol 43, 351–354.
  • Hojsak, I., Snovak, N., Abdovic, S., Szajewska, H., Misak, Z. and Kolacek, S. (2010) Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr 29, 312–316.
  • Van Hoogmoed, C.G., Geertsema-Doornbusch, G.I., Teughels, W., Quirynen, M., Busscher, H.J. and Van der Mei, H.C. (2008) Reduction of periodontal pathogens adhesion by antagonistic strains. Oral Microbiol Immunol 23, 43–48.
    Direct Link:
  • Ishijima, S.A., Hayama, K., Burton, J.P., Reid, G., Okada, M., Matsushita, Y. and Abe, S. (2012) Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model. Appl Environ Microbiol 78, 2190–2199.
  • Jankowska, A., Laubitz, D., Antushevich, H., Zabielski, R. and Grzesiuk, E. (2008) Competition of Lactobacillus paracasei with Salmonella enterica for adhesion to Caco-2 cells. J Biomed Biotechnol 2008, 357964.
  • Kalliomaki, M. and Isolauri, E. (2003) Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 3, 15–20.
  • Khalil, R. (2009) Evidence for probiotic potential of a capsular-producing Streptococcus thermophilus CHCC 3534 strain. Pol J Microbiol 58, 49–55.
  • Kimoto, H., Kurisaki, J., Tsuji, N.M., Ohmomo, S. and Okamoto, T. (1999) Lactococci as probiotic strains: adhesion to human enterocyte-like Caco-2 cells and tolerance to low pH and bile. Lett Appl Microbiol 29, 313–316.
    Direct Link:
  • Klarin, B., Johansson, M.L., Molin, G., Larsson, A. and Jeppsson, B. (2005) Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit Care 9, R285–R293.
  • Lee, Y.K. and Puong, K.Y. (2002) Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate. Br J Nutr 88(Suppl 1), S101–S108.
  • Lepargneur, J.P. and Rousseau, V. (2002) Protective role of the Doderlein flora. J Gynecol Obstet Biol Reprod (Paris) 31, 485–494.
  • Leyer, G.J., Li, S., Mubasher, M.E., Reifer, C. and Ouwehand, A.C. (2009) Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124, e172–e179.
  • Mack, D.R., Michail, S., Wei, S., McDougall, L. and Hollingsworth, M.A. (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276, G941–G950.
  • MacPhee, R.A., Hummelen, R., Bisanz, J.E., Miller, W.L. and Reid, G. (2010) Probiotic strategies for the treatment and prevention of bacterial vaginosis. Expert Opin Pharmacother 11, 2985–2995.
  • Makino, S., Ikegami, S., Kume, A., Horiuchi, H., Sasaki, H. and Orii, N. (2010) Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Br J Nutr 104, 998–1006.
  • Masdea, L., Kulik, E.M., Hauser-Gerspach, I., Ramseier, A.M., Filippi, A. and Waltimo, T. (in press) Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch Oral Biol doi: 10.1016/j.archoralbio.2012.02.011.
  • Meijer, B.J. and Dieleman, L.A. (2011) Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J Clin Gastroenterol 45(Suppl), S139–S144.
  • Merenstein, D., Murphy, M., Fokar, A., Hernandez, R.K., Park, H., Nsouli, H., Sanders, M.E., Davis, B.A. et al. (2010) Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr 64, 669–677.
  • Merk, K., Borelli, C. and Korting, H.C. (2005) Lactobacilli – bacteria-host interactions with special regard to the urogenital tract. Int J Med Microbiol 295, 9–18.
  • Miyata, E., Satoh, S., Inokuchi, K., Aso, A., Kimura, Y., Yokoyama, S., Mori, E., Nakamura, T. et al. (2007) Three fatal cases of rapidly progressive infective endocarditis caused by Staphylococcus aureus: one case with huge vegetation. Circ J 71, 1488–1491.
  • Morelli, L., Garbagna, N., Rizzello, F., Zonenschain, D. and Grossi, E. (2006) In vivo association to human colon of Lactobacillus paracasei B21060: map from biopsies. Dig Liver Dis 38, 894–898.
  • Nyawo, B., Shoaib, R.F., Evemy, K. and Clark, S.C. (2007) Infective endocarditis during pregnancy: case report. Heart Surg Forum 10, E480–E481.
  • Oelschlaeger, T.A. (2010) Mechanisms of probiotic actions – a review. Int J Med Microbiol 300, 57–62.
  • Okahashi, N., Nakata, M., Sakurai, A., Terao, Y., Hoshino, T., Yamaguchi, M., Isoda, R., Sumitomo, T. et al. (2010) Pili of oral Streptococcus sanguinis bind to fibronectin and contribute to cell adhesion. Biochem Biophys Res Commun 391, 1192–1196.
  • Okahashi, N., Nakata, M., Terao, Y., Isoda, R., Sakurai, A., Sumitomo, T., Yamaguchi, M., Kimura, R.K. et al. (2011) Pili of oral Streptococcus sanguinis bind to salivary amylase and promote the biofilm formation. Microb Pathog 50, 148–154.
  • O'Toole, P.W. and Cooney, J.C. (2008) Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdiscip Perspect Infect Dis 2008, 175285.
  • Ouwehand, A.C., Salminen, S. and Isolauri, E. (2002) Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 82, 279–289.
  • Ozdemir, O. (2010) Any benefits of probiotics in allergic disorders? Allergy Asthma Proc 31, 103–111.
  • Pascual, L.M., Daniele, M.B., Ruiz, F., Giordano, W., Pajaro, C. and Barberis, L. (2008) Lactobacillus rhamnosus L60, a potential probiotic isolated from the human vagina. J Gen Appl Microbiol 54, 141–148.
  • Perea Velez, M., Hermans, K., Verhoeven, T.L., Lebeer, S.E., Vanderleyden, J. and De Keersmaecker, S.C. (2007) Identification and characterization of starter lactic acid bacteria and probiotics from Columbian dairy products. J Appl Microbiol 103, 666–674.
    Direct Link:
  • Pichichero, M. (2007) Clinical Management of Streptococcal Pharyngitis. West Islip, NY: Professional Communications, Inc.
  • Princivalli, M.S., Paoletti, C., Magi, G., Palmieri, C., Ferrante, L. and Facinelli, B. (2009) Lactobacillus rhamnosus GG inhibits invasion of cultured human respiratory cells by prtF1-positive macrolide-resistant group A streptococci. Lett Appl Microbiol 48, 368–372.
    Direct Link:
  • Ramiah, K., van Reenen, C.A. and Dicks, L.M. (2008) Surface-bound proteins of Lactobacillus plantarum 423 that contribute to adhesion of Caco-2 cells and their role in competitive exclusion and displacement of Clostridium sporogenes and Enterococcus faecalis. Res Microbiol 159, 470–475.
  • Rautava, S., Salminen, S. and Isolauri, E. (2009) Specific probiotics in reducing the risk of acute infections in infancy–a randomised, double-blind, placebo-controlled study. Br J Nutr 101, 1722–1726.
  • Del Re, B., Sgorbati, B., Miglioli, M. and Palenzona, D. (2000) Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett Appl Microbiol 31, 438–442.
    Direct Link:
  • Reid, G. (2001) Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 73, 437S–443S.
  • Reid, G., Cook, R.L. and Bruce, A.W. (1987) Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol 138, 330–335.
  • Renton, B.J., Clague, J.E. and Cooke, R.P. (2009) Streptococcus oralis endocarditis presenting as infective discitis in an edentulous patient. Int J Cardiol 137, e13–e14.
  • Roos, K., Grahn, E., Holm, S.E., Johansson, H. and Lind, L. (1993a) Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otorhinolaryngol 25, 141–148.
  • Roos, K., Holm, S.E., Grahn, E. and Lind, L. (1993b) Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis 25, 31–35.
  • Roos, K., Holm, S.E., Grahn-Hakansson, E. and Lagergren, L. (1996) Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis–a randomized placebo-controlled multicentre study. Scand J Infect Dis 28, 459–462.
  • Roos, K., Hakansson, E.G. and Holm, S. (2001) Effect of recolonisation with “interfering” alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. BMJ 322, 210–212.
  • Skovbjerg, S., Roos, K., Holm, S.E., Grahn Hakansson, E., Nowrouzian, F., Ivarsson, M., Adlerberth, I. and Wold, A.E. (2009) Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child 94, 92–98.
  • Sliepen, I., Van Essche, M., Loozen, G., Van Eldere, J., Quirynen, M. and Teughels, W. (2009) Interference with Aggregatibacter actinomycetemcomitans: colonization of epithelial cells under hydrodynamic conditions. Oral Microbiol Immunol 24, 390–395.
    Direct Link:
  • Sookkhee, S., Chulasiri, M. and Prachyabrued, W. (2001) Lactic acid bacteria from healthy oral cavity of Thai volunteers: inhibition of oral pathogens. J Appl Microbiol 90, 172–179.
    Direct Link:
  • Stamatova, I. and Meurman, J.H. (2009b) Probiotics: health benefits in the mouth. Am J Dent 22, 329–338.
  • Stamatova, I., Kari, K., Vladimirov, S. and Meurman, J.H. (2009a) In vitro evaluation of yoghurt starter lactobacilli and Lactobacillus rhamnosus GG adhesion to saliva-coated surfaces. Oral Microbiol Immunol 24, 218–223.
    Direct Link:
  • Taipale, T., Pienihakkinen, K., Isolauri, E., Larsen, C., Brockmann, E., Alanen, P., Jokela, J. and Soderling, E. (2011) Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr 105, 409–416.
  • Tano, K., Grahn Hakansson, E., Holm, S.E. and Hellstrom, S. (2002) A nasal spray with alpha-haemolytic streptococci as long term prophylaxis against recurrent otitis media. Int J Pediatr Otorhinolaryngol 62, 17–23.
  • Taverniti, V., Minuzzo, M., Arioli, S., Junttila, I., Hamalainen, S., Turpeinen, H., Mora, D., Karp, M. et al. (2012) In vitro functional and immunomodulatory properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 association that are relevant to the development of a pharyngeal probiotic product. Appl Environ Microbiol 78, 4209–4216.
  • Tuomola, E.M. and Salminen, S.J. (1998) Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 41, 45–51.
  • Twetman, L., Larsen, U., Fiehn, N.E., Stecksen-Blicks, C. and Twetman, S. (2009) Coaggregation between probiotic bacteria and caries-associated strains: an in vitro study. Acta Odontol Scand 67, 1–5.
  • Uehara, Y., Nakama, H., Agematsu, K., Uchida, M., Kawakami, Y., Abdul Fattah, A.S. and Maruchi, N. (2000) Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp. J Hosp Infect 44, 127–133.
  • Vesterlund, S., Karp, M., Salminen, S. and Ouwehand, A.C. (2006) Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria. Microbiology 152, 1819–1826.
  • Vizoso Pinto, M.G., Schuster, T., Briviba, K., Watzl, B., Holzapfel, W.H. and Franz, C.M. (2007) Adhesive and chemokine stimulatory properties of potentially probiotic Lactobacillus strains. J Food Prot 70, 125–134.
  • Vlkova, E., Rada, V., Smehilova, M. and Killer, J. (2008) Auto-aggregation and co-aggregation ability in bifidobacteria and clostridia. Folia Microbiol (Praha) 53, 263–269.
  • de Vrese, M., Winkler, P., Rautenberg, P., Harder, T., Noah, C., Laue, C., Ott, S., Hampe, J. et al. (2005) Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 24, 481–491.
  • de Vrese, M., Winkler, P., Rautenberg, P., Harder, T., Noah, C., Laue, C., Ott, S., Hampe, J. et al. (2006) Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24, 6670–6674.
  • Weizman, Z., Asli, G. and Alsheikh, A. (2005) Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115, 5–9.
  • Yu, H. (2011) Bacteria-mediated disease therapy. Appl Microbiol Biotechnol 92, 1107–1113.
  • Zarate, G. and Nader-Macias, M.E. (2006) Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett Appl Microbiol 43 174–180.
    Direct Link:
View Full Article (HTML) Get PDF (144K)